Literature DB >> 9361309

Ocular manifestations of autosomal recessive Alport syndrome.

D Colville1, J Savige, M Morfis, J Ellis, P Kerr, J Agar, R Fasset.   

Abstract

Ocular abnormalities are common in X-linked Alport syndrome, but they have not been studied in patients with the rarer autosomal recessive disease. We have examined the eyes of a family with autosomal recessive Alport syndrome. Four of the eight offspring of a consanguineous marriage had renal failure and deafness by the age of 20 years. The diagnosis of Alport syndrome was confirmed on the ultrastructural demonstration of a lamellated glomerular basement membrane (GBM) in one affected family member. Autosomal recessive inheritance was suggested by the lack of linkage to the COL4A5/COL4A6 locus, and by linkage to the COL4A3/COL4A4 locus. All four affected family members had anterior lenticonus (or had had a lens replacement for this) and the three who were examined had a dot-and-fleck retinopathy. Neither of the two unaffected offspring who were examined nor the father had these abnormalities. The ocular manifestations of autosomal recessive Alport syndrome are probably identical to those for the X-linked form. Although the mutations in these diseases affect genes for different type IV collagen chains, these chains occur together in the basement membranes of the kidney, eye and ear, and abnormalities in any one may result in the same clinical phenotype.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9361309     DOI: 10.3109/13816819709057125

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  18 in total

Review 1.  Living donor kidney transplantation in patients with hereditary nephropathies.

Authors:  Patrick Niaudet
Journal:  Nat Rev Nephrol       Date:  2010-09-28       Impact factor: 28.314

Review 2.  The collagenopathies: review of clinical phenotypes and molecular correlations.

Authors:  Rebekah Jobling; Rohan D'Souza; Naomi Baker; Irene Lara-Corrales; Roberto Mendoza-Londono; Lucie Dupuis; Ravi Savarirayan; L Ala-Kokko; Peter Kannu
Journal:  Curr Rheumatol Rep       Date:  2014-01       Impact factor: 4.592

3.  Clinical and genetic features in autosomal recessive and X-linked Alport syndrome.

Authors:  Yanyan Wang; Vanessa Sivakumar; Mardhiah Mohammad; Deb Colville; Helen Storey; Frances Flinter; Hayat Dagher; Judy Savige
Journal:  Pediatr Nephrol       Date:  2013-11-02       Impact factor: 3.714

4.  A novel COL4A3 mutation causes autosomal-recessive Alport syndrome in a large Turkish family.

Authors:  Asli Subasioglu Uzak; Bulent Tokgoz; Munis Dundar; Mustafa Tekin
Journal:  Genet Test Mol Biomarkers       Date:  2013-01-08

Review 5.  Genotype-phenotype correlations in pathology caused by collagen type IV alpha 1 and 2 mutations.

Authors:  Marion Jeanne; Douglas B Gould
Journal:  Matrix Biol       Date:  2016-10-26       Impact factor: 11.583

Review 6.  Alport syndrome--insights from basic and clinical research.

Authors:  Jenny Kruegel; Diana Rubel; Oliver Gross
Journal:  Nat Rev Nephrol       Date:  2012-11-20       Impact factor: 28.314

7.  The use of ocular abnormalities to diagnose X-linked Alport syndrome in children.

Authors:  Ke Wei Zhang; Deb Colville; Rachel Tan; Colin Jones; Stephen I Alexander; Jeffrey Fletcher; Judy Savige
Journal:  Pediatr Nephrol       Date:  2008-03-15       Impact factor: 3.714

Review 8.  Familial hematuria.

Authors:  Clifford E Kashtan
Journal:  Pediatr Nephrol       Date:  2007-10-02       Impact factor: 3.714

9.  Bilateral anterior lenticonus in a case of Alport syndrome: a clinical and histopathological correlation after successful clear lens extraction.

Authors:  Shilpa Sonarkhan; Muralidhar Ramappa; Sunita Chaurasia; Kaustubh Mulay
Journal:  BMJ Case Rep       Date:  2014-06-26

10.  Developmental distribution of collagen IV isoforms and relevance to ocular diseases.

Authors:  Xiaoyang Bai; David J Dilworth; Yi-Chinn Weng; Douglas B Gould
Journal:  Matrix Biol       Date:  2009-03-09       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.